Bitech Technologies CORP F-1 registration statements

The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.

NASDAQ
Black Titan Corporation has filed a Certificate of Designations for its Series B Convertible Preferred Shares, outlining the terms, preferences, and limitations of these shares.
NASDAQ
Black Titan Corporation finalized its business combination with Titan Pharmaceuticals and TalenTec, but the combined entity projects a substantial pro forma net loss and faces high market volatility.
NASDAQ
Black Titan Corporation filed an F-1 registration statement for the resale of up to 4,517,483 ordinary shares by selling shareholders following its business combination with Titan Pharmaceuticals, Inc. and TalenTec Sdn. Bhd.
NASDAQ
Black Titan Corporation filed an F-1 registration statement for the resale of up to 4,517,483 ordinary shares by selling shareholders following its business combination with Titan Pharmaceuticals and TalenTec.